Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Bio Key International (BKYI) over the last 17 years, with Q3 2025 value amounting to -$1.1 million.

  • Bio Key International's Cash from Operations rose 1200.74% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year increase of 1471.34%. This contributed to the annual value of -$2.9 million for FY2024, which is 2318.16% up from last year.
  • Bio Key International's Cash from Operations amounted to -$1.1 million in Q3 2025, which was up 1200.74% from -$880012.0 recorded in Q2 2025.
  • Bio Key International's Cash from Operations' 5-year high stood at $297084.0 during Q1 2024, with a 5-year trough of -$3.2 million in Q1 2021.
  • Over the past 5 years, Bio Key International's median Cash from Operations value was -$1.4 million (recorded in 2024), while the average stood at -$1.3 million.
  • The largest annual percentage gain for Bio Key International's Cash from Operations in the last 5 years was 11540.24% (2024), contrasted with its biggest fall of 75383.37% (2024).
  • Over the past 5 years, Bio Key International's Cash from Operations (Quarter) stood at -$1.9 million in 2021, then decreased by 1.62% to -$1.9 million in 2022, then increased by 19.42% to -$1.5 million in 2023, then surged by 66.4% to -$514564.0 in 2024, then tumbled by 118.2% to -$1.1 million in 2025.
  • Its last three reported values are -$1.1 million in Q3 2025, -$880012.0 for Q2 2025, and -$835312.0 during Q1 2025.